Third Quarter Financial Highlights: Total revenues decreased $17.4 million year over year to $448.8 million Construction Equipment and Material Handling […]
Advancing investigation of [212Pb]VMT01 as a monotherapy and in combination with the anti-PD-1 antibody, nivolumab, in patients with previously treated […]
QIAGEN und die McGill University initiieren gemeinsame Projekte im Bereich der Mikrobiomforschung, um evidenzbasiertes Wissen für die Medizin und die […]